Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT05113160
Eligibility Criteria:
Criteria for All Treatment Cycles:
Inclusion Criteria:
* Clinical diagnosis of aphasia
* At least 6 months post-onset of stroke in the language-dominant hemisphere.
* Native English speakers
* Demonstrate sufficient auditory comprehension skills to participate in a supported conversation, based on results of standardized aphasia tests
Exclusion
* No history of neurological disease (other than stroke)
* No history of developmental speech, language, or learning disabilities
* No current serious medical illness (e.g., cancer)
* Participants will be asked to abstain from concurrent speech language treatment.
Separate criteria for Treatment Cycles 1, 2, and 3 based on aphasia severity:
Cycle 1 Severity-based Inclusion Criteria (Completed 2022):
\-- All aphasia profiles and severity levels.
Cycle 2 Severity-based Inclusion Criteria (Completed 2023):
\-- Participants with severe aphasia
Cycle 3 Severity-based Inclusion Criteria (Completed 2024):
\-- Participants with mild-moderate aphasia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05113160
Study Brief:
Protocol Section:
NCT05113160